IFI204-STING drives protective innate immunity against gangrenous Clostridium perfringens infection via regulation of NLRP3 signaling

Read full text Summarise with VIRAT
Authors: Mingyue Zhang, Jia-Qi Li, Qian Xu, Zi-Jian Zhuang, Jing Liang, Ao-Bo He, Shu-Xin Zhang, Yi Zhao, Xue Chen, Zhen-Yu Li, Shengping, Yang Liu
+1 more Shui-Xing Yu
Cited by: 0
References: 60

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Inflammasomes are an essential component of the innate immune response against pathogen infections. However, the molecular mechanism regulating the inflammasome signaling in response to gangrenous Clostridium perfringens ( C. perfringens ) infection remains elusive. We herein report the unexpected discovery that IFI204 (the murine homolog of human IFI16)–dependent STING protects against C. perfringens gas gangrene via enhancing NLRP3 inflammasome signaling. In the C. perfringens gas gangrene model, compared with wild-type (WT) mice, Sting deficiency ( Sting -/- ) mice displayed an increased susceptibility to C. perfringens soft tissue infection, with more bacterial colonization, severe muscle damage, and higher mortality rates. Obviously, Sting deficiency leads to the defect of inflammasome signaling activation and bacterial killing and clearance. STING promotes inflammasome signaling activation in an IFI204-dependent manner. Crucially, the IFI204-STING axis enhances NLRP3 inflammasome signaling activation, which, in turn, facilitates pathogen elimination and host defense. Our findings highlight STING acts as a positive regulator in defense of C. perfringens infection and present it as a potential target for anti-infection drug development.

Fields of Study & Subjects

Inflammasome and immune disorders interferon and immune responses Immune Response and Inflammation

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1715595–1715595
Publication date
31 March 2026
Language
EN